Thompson Rahsaan sold ZVRA
June 22, 2026 · Form 4 insider transaction
Thompson Rahsaan sold 34,557 shares of Zevra Therapeutics, Inc. at $12.68 per share, a transaction worth $438.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
34,557
Price
$12.68
Total value
$438.3K
InsiderThompson Rahsaan
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 22, 2026
Filing dateJune 23, 2026
Shares owned after80,235
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Adoption date of referenced 10b5-1(c) plan is: 01-08-2026.; This transaction was executed in multiple trades at prices ranging from $12.53 to $13.19. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.